参考文献:1. Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri P. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm. 2001;51:93鈥?09. CrossRef 2. Yu S, Zhao Y, Wu F, Zhang X, Lu W, Zhang H, / et al. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. Int J Pharm. 2004;281:11鈥?3. CrossRef 3. Jeon SO, Hwang HJ, Oh DH, Seo JE, Chun KH, Hong SM, / et al. Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system. J Microencapsul. 2012;29:234鈥?1. CrossRef 4. Lee HE, Lee MJ, Park CR, Kim AY, Chun KH, Hwang HJ, / et al. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery. J Control Release. 2010;143:251鈥?. CrossRef 5. Oh DH, Chun KH, Jeon SO, Kang JW, Lee S. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur J Pharm Biopharm. 2011;79:357鈥?3. CrossRef 6. Hoogstraateand AJ, Wertz PW. Drug delivery via the buccal mucosa. Pharm SciTechnol Today. 1998;1:309鈥?6. CrossRef 7. Chen LL, Chetty DJ, Chien YW. A mechanistic analysis to characterize oramucosal permeation properties. Int J Pharm. 1999;184:63鈥?2. CrossRef 8. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci. 1998;1:15鈥?0. 9. Hoogstraate AJ, Wertz PW, Squier CA, Geest AB, Abraham W, Garrison MD, / et al. Effects of the penetration enhancer glycodeoxycholate on the lipid integrity in porcine buccal epithelium in vitro. Eur J Pharm Sci. 1997;5:189鈥?8. CrossRef 10. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery 鈥?a promising option for orally less efficient drugs. J Control Release. 2006;114:15鈥?0. CrossRef 11. Pillaiand O, Panchagnula R. Transdermal iontophoresis of insulin. J Control Release. 2003;88:287鈥?6. CrossRef 12. Giannola LI, De Caro V, Giandalia G, Siragusa MG, Campisi G, Florena AM, / et al. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur J Pharm Biopharm. 2007;65:238鈥?6. CrossRef 13. Jacobsen J. Buccal iontophoretic delivery of atenolol.HCl employing a new in vitro three-chamber permeation cell. J Control Release. 2001;70:83鈥?5. CrossRef 14. Patel MP, Churchman ST, Cruchley AT, Braden M, Williams DM. Electrically induced transport of macromolecules through oral buccal mucosa. Dent Mater. 2013;29:674鈥?1. official publication of the Academy of Dental Materials. CrossRef 15. Patel MP, Churchman ST, Cruchley AT, Braden M, Williams DM. Delivery of macromolecules across oral mucosa from polymeric hydrogels is enhanced by electrophoresis (iontophoresis). Dent Mater. 2013;29:e299鈥?07. official publication of the Academy of Dental Materials. CrossRef 16. Chaturvedula A, Joshi DP, Anderson C, Morris RL, Sembrowich WL, Banga AK. In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. Int J Pharm. 2005;297:190鈥?. 17. Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone. 2002;30:80S鈥?S. CrossRef 18. Visser EJ. A review of calcitonin and its use in the treatment of acute pain. Acute Pain. 2005;7:185鈥?. CrossRef 19. Chang SL, Hofmann GA, Zhang L, Deftos LJ, Banga AK. Transdermal iontophoretic delivery of salmon calcitonin. Int J Pharm. 2000;200:107鈥?3. CrossRef 20. Kitano M, Maitani Y, Takayama K, Nagai T. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17尾-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm. 1998;174:19鈥?8. CrossRef 21. Shojaei AH, Chang RK, Guo X, Burnside BA, Couch RA. Systemic drug delivery via the buccal mucosal route. Pharm Technol. 2001;25:70鈥?1. 22. Lee KC, Lee YJ, Song HM, Chun CJ, DeLuca PP. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm Res. 1992;9:1521鈥?. CrossRef 23. Gandhiand RB, Robinson JR. Permselective characteristics of rabbit buccal mucosa. Pharm Res. 1991;8:1199鈥?02. CrossRef 24. Wang X, Zheng C, Wu Z, Teng D, Zhang X, Wang Z, / et al. Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res B Appl Biomater. 2009;88:150鈥?1. CrossRef 25. J.D. Smart. The role of water movement and polymer hydration in mucoadhesion. Bioadhesive drug delivery systems: fundamentals, novel approaches and development:11鈥?3 (1999). 26. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004;56:619鈥?8. CrossRef 27. Dondeti P, Zia H, Needham TE. In vivo evaluation of spray formulations of human insulin for nasal delivery. Int J Pharm. 1995;122:91鈥?05. CrossRef 28. Schipper NGM, Verhoef JC, Romeijn SG, Merkus FWHM. Methylated 尾-cyclodextrins are able to improve the nasal absorption of salmon calcitonin. Calcif Tissue Int. 1995;56:280鈥?. CrossRef 29. Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers鈥揾ow do they really work? J Control Release. 2005;105:1鈥?5. CrossRef 30. 艦enel S, 陌kinci G, Ka艧 S, Yousefi-Rad A, Sargon MF, H谋ncal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm. 2000;193:197鈥?03. CrossRef 31. Matsuyama T, Morita T, Horikiri Y, Yamahara H, Yoshino H. Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant. J Control Release. 2006;110:347鈥?2. CrossRef 32. Rochat T, Lacroix JS, Jornot L. N-acetylcysteine inhibits Na鈥?鈥塧bsorption across human nasal epithelial cells. J Cell Physiol. 2004;201:106鈥?6. CrossRef 33. Gillissenand A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med. 1998;92:609鈥?3. CrossRef 34. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101鈥?4. CrossRef 35. Huwyler R, Born W, Ohnhaus EE, Fischer JA. Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man. Am J Physiol. 1979;236:E15鈥?9. 36. Millest AJ, Evans JR, Young JJ, Johnstone D. Sustained release of salmon calcitonin in vivo from lactide: glycolide copolymer depots. Calcif Tissue Int. 1993;52:361鈥?. CrossRef 37. Swarnakar NK, Jain V, Dubey V, Mishra D, Jain NK. Enhanced oromucosal delivery of progesterone via hexosomes. Pharm Res. 2007;24:2223鈥?0. CrossRef 38. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 2001;219:95鈥?05. CrossRef 39. Takahashi K, Sakano H, Yoshida M, Numata N, Mizuno N. Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin. J Control Release. 2001;73:351鈥?. CrossRef 40. Bhatia KS, Gao S, Singh J. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin. J Control Release. 1997;47:81鈥?. CrossRef 41. Hoogstraate AJ, Senel S, Cullander C, Verhoef J, Junginger HE, Bodd HE. Effects of bile salts on transport rates and routes of FITC-labelled compounds across porcine buccal epithelium in vitro. J Control Release. 1996;40:211鈥?1. CrossRef 42. Meaneyaand C, O鈥橠riscoll C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur J Pharm Sci. 1999;8:167鈥?5. CrossRef 43. Prasad R, Anand S, Koul V. Biophysical assessment of DC iontophoresis and current density on transdermal permeation of methotrexate. Int J Pharm Investig. 2011;1:234鈥?. CrossRef 44. Nugroho AK, Li L, Dijkstra D, Wikstr枚m H, Danhof M, Bouwstra JA. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro. J Control Release. 2005;103:393鈥?03. CrossRef 45. Kottgen M, Busch AE, Hug MJ, Greger R, Kunzelmann K. N-Acetyl-L-cysteine and its derivatives activate a Cl- conductance in epithelial cells. Pflugers Arch. 1996;431:549鈥?5. CrossRef 46. Dhiman MK, Dhiman A, Sawant KK. Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study. AAPS PharmSciTech. 2009;10:258鈥?5. CrossRef 47. Zhang J, Niu S, Ebert C, Stanley TH. An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage. Int J Pharm. 1994;101:15鈥?2. CrossRef
刊物类别:Biomedical and Life Sciences
刊物主题:Biomedicine Pharmacology and Toxicology Pharmacy Biochemistry Medical Law Biomedical Engineering